SomnoMed Management
Management criteria checks 3/4
SomnoMed's CEO is Neil Verdal-Austin, appointed in Nov 2018, has a tenure of 5.42 years. total yearly compensation is A$817.36K, comprised of 67.4% salary and 32.6% bonuses, including company stock and options. directly owns 1.61% of the company’s shares, worth A$449.83K. The average tenure of the management team and the board of directors is 4.8 years and 3.7 years respectively.
Key information
Neil Verdal-Austin
Chief executive officer
AU$817.4k
Total compensation
| CEO salary percentage | 67.4% |
| CEO tenure | 5.4yrs |
| CEO ownership | 1.6% |
| Management average tenure | 4.8yrs |
| Board average tenure | 3.7yrs |
Recent management updates
Recent updates
SomnoMed Limited (ASX:SOM) Stock's 43% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Apr 15
SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Mar 04Market Still Lacking Some Conviction On SomnoMed Limited (ASX:SOM)
Dec 21SomnoMed Limited (ASX:SOM) Could Be Riskier Than It Looks
Sep 02Is SomnoMed (ASX:SOM) Using Too Much Debt?
Jun 19It's Unlikely That SomnoMed Limited's (ASX:SOM) CEO Will See A Huge Pay Rise This Year
Nov 18SomnoMed (ASX:SOM) Has Debt But No Earnings; Should You Worry?
Sep 27Is SomnoMed (ASX:SOM) Using Debt Sensibly?
May 10Is SomnoMed (ASX:SOM) Using Debt Sensibly?
Oct 26Health Check: How Prudently Does SomnoMed (ASX:SOM) Use Debt?
May 12Could The SomnoMed Limited (ASX:SOM) Ownership Structure Tell Us Something Useful?
Mar 02Have Insiders Been Buying SomnoMed Limited (ASX:SOM) Shares?
Feb 01
Is SomnoMed (ASX:SOM) Using Debt In A Risky Way?
Dec 28Is SomnoMed Limited (ASX:SOM) Trading At A 38% Discount?
Dec 01Analysts Just Published A Bright New Outlook For SomnoMed Limited's (ASX:SOM)
Jul 28SomnoMed Limited (ASX:SOM) Insiders Increased Their Holdings
Jul 14CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$11m |
| Sep 30 2023 | n/a | n/a | -AU$9m |
| Jun 30 2023 | AU$817k | AU$551k | -AU$8m |
| Mar 31 2023 | n/a | n/a | -AU$7m |
| Dec 31 2022 | n/a | n/a | -AU$5m |
| Sep 30 2022 | n/a | n/a | -AU$5m |
| Jun 30 2022 | AU$1m | AU$505k | -AU$4m |
| Mar 31 2022 | n/a | n/a | -AU$5m |
| Dec 31 2021 | n/a | n/a | -AU$5m |
| Sep 30 2021 | n/a | n/a | -AU$3m |
| Jun 30 2021 | AU$670k | AU$393k | -AU$1m |
| Mar 31 2021 | n/a | n/a | -AU$867k |
| Dec 31 2020 | n/a | n/a | -AU$651k |
| Sep 30 2020 | n/a | n/a | -AU$545k |
| Jun 30 2020 | AU$569k | AU$384k | -AU$438k |
| Mar 31 2020 | n/a | n/a | AU$190k |
| Dec 31 2019 | n/a | n/a | AU$819k |
| Sep 30 2019 | n/a | n/a | AU$390k |
| Jun 30 2019 | AU$609k | AU$402k | -AU$39k |
| Mar 31 2019 | n/a | n/a | AU$2m |
| Dec 31 2018 | n/a | n/a | AU$3m |
| Sep 30 2018 | n/a | n/a | AU$3m |
| Jun 30 2018 | AU$472k | AU$366k | AU$2m |
| Mar 31 2018 | n/a | n/a | -AU$718k |
| Dec 31 2017 | n/a | n/a | -AU$4m |
| Sep 30 2017 | n/a | n/a | -AU$4m |
| Jun 30 2017 | AU$549k | AU$366k | -AU$3m |
Compensation vs Market: Neil's total compensation ($USD523.11K) is above average for companies of similar size in the Australian market ($USD288.89K).
Compensation vs Earnings: Neil's compensation has been consistent with company performance over the past year.
CEO
Neil Verdal-Austin
5.4yrs
Tenure
AU$817,357
Compensation
Mr. Neil Verdal-Austin, BComm (Hons), CA, serves as a Managing Director and Director at SomnoMed Limited since August 24, 2020. He has been the Global Chief Executive of SomnoMed Limited since November 19,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Global CEO | 5.4yrs | AU$817.36k | 1.61% A$ 449.8k | |
| Vice President of Global Marketing | 4.8yrs | AU$505.38k | 0.13% A$ 37.2k | |
| Executive VP of Sales & Marketing - North America | 4.5yrs | AU$623.78k | 0.078% A$ 21.8k | |
| Vice President of Marketing & Sales - Europe | no data | AU$525.51k | no data | |
| Chief Financial Officer | less than a year | no data | no data | |
| Company Secretary | 29.3yrs | AU$35.38k | no data | |
| Vice President of Global Production and Product Development | no data | AU$239.95k | no data |
4.8yrs
Average Tenure
Experienced Management: SOM's management team is considered experienced (4.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Global CEO | 3.7yrs | AU$817.36k | 1.61% A$ 449.8k | |
| Non-Executive Director | 3.7yrs | AU$92.34k | 0.10% A$ 29.1k | |
| Member of the Medical Advisory Board | no data | no data | no data | |
| Member of the Medical Advisory Board | no data | no data | no data | |
| Chairman of the Medical Advisory Board | no data | no data | no data | |
| Chairman of the Board | 3.7yrs | AU$184.68k | 0.40% A$ 112.5k | |
| Non-Executive Director | 5.9yrs | AU$91.21k | no data | |
| Non-Executive Director | 3.4yrs | AU$91.21k | no data | |
| Non-Executive Director | 3.7yrs | AU$91.21k | 0.11% A$ 29.5k |
3.7yrs
Average Tenure
Experienced Board: SOM's board of directors are considered experienced (3.7 years average tenure).